IRCT20190714044199N1
Recruiting
Phase 3
Evaluating the efficacy of adding N-Acetyl cysteine to risperidone treatment regimen in patients with autism spectrum disorder
Medical Science University of Mashhad0 sites66 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Autism spectrum disorder.
- Sponsor
- Medical Science University of Mashhad
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Autism spectrum disorder (ASD) patients aging between 3 to 12
- •Having parental informed consent
- •IQ score greater than 50 based on Wildland Test
- •Receiving risperidone therapy for at least one month
- •Lack of clear organic disease (based on family history and medical records) Clear organic causes include visual and hearing impairment, seizures, trauma cycles, chronic or acute medical disorder, and brain dysfunction.
- •Psychiatric disorders including Toure's syndrome, Fragile X syndrome, schizophrenia, Attension deficit hyperactivity disorder (ADHD) based on structured psychiatric interview conducted by pediatric psychiatrist
Exclusion Criteria
- •If the parents do not cooperate for any reason after entering the study 2\- 3\-
- •Use of any psychotropic drugs other than risperidone
- •Any unbearable or life\-threatening drug side effect or any other illness that requires medication which may interfere with results of this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of The Effect of N-acetylcysteine in The Prevention of Vancomycin-Induced Renal Disorder.IRCT20150721023282N6Esfahan University of Medical Sciences60
Recruiting
Phase 2
Effect of N-acetylcysteine in the improvement of AphthousRecurrent aphthous stomatitis.Recurrent oral aphthaeIRCT20180728040614N1Sari University of Medical Sciences46
Completed
Phase 3
Evaluation the effect of N Acetyl Cystein (NAC) in myocardial infarctioIRCT20200519047506N1Karaj University of Medical Sciences142
Not yet recruiting
Phase 3
The effect of N-Acetylcysteine on COVID-19IRCT20200509047364N3Bandare-abbas University of Medical Sciences40
Not yet recruiting
Phase 3
Evaluation the effects of N-acetyl Cysteine on diabetic foot ulcerDiabetic Foot Ulcer.Diabetes mellitus due to underlying condition with foot ulcerE08.621IRCT20130917014693N17Shahid Beheshti University of Medical Sciences100